Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto.
Schedule
Product: Malarone Paediatric
Active Ingredients: Atovaquone 62.5mg
Proguanil hydrochloride 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: GlaxoSmithKline Inc, Mississauga, Ontario, Canada
Dated this 1st day of November 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).